SNN Smith & Nephew (SNN) Insider Trading, Ownership & Congress Trades

Medical Devices · Orthopedic, prosthetic & surgical appliances & supplies · CIK 0000845982

Quote by TradingView

SEC filings

Insider buyers, 180 days

House members buying, 1 year

STOCK Act, US House only, disclosed up to 45 days after the trade

Funds added, last quarter

171

13F, latest reported quarter

What the filings say about SNN

Congress, 1 year

No trades

Last one: sale, 2025-06-17

Smith & Nephew insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for SMITH & NEPHEW PLC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: its insiders are exempt from SEC Form 4 and report in the home market, so their buys and sells do not appear here.

Insider

Filed

Value

Since filing

no insider purchases or sales on record

0 transactions on record

See all insider buying · insider selling

Seven facts, ranked against the sector · Rank is not a forecast

Insiders

no insider buys or sells on file

Congress

no House purchase disclosed in the last 12 months

Funds

171 funds bought in last quarter

more than 79% of Medical Devices

Revenue

no revenue reported in any filing

Margin

no margin: no revenue reported

Buybacks

no share repurchases reported

Short interest

0.5% of shares outstanding short · 3.1 days to cover · settled 2026-10-15

below 77% of Medical Devices

The situation: each line is one rule over one dataset

2 trial completion dates slipped in the last 90 days.

What changed in the last 30 days

Nothing new filed in the last 30 days

Watch SNN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns SNN: institutional holders (13F)

13F holdings, latest reported quarter

River Road Asset Management, LLC

3,221,876 sh

$92.8M

GOLDMAN SACHS GROUP INC

3,069,598 sh

$88.4M

BRANDES INVESTMENT PARTNERS, LP

2,148,731 sh

$61.9M

DIMENSIONAL FUND ADVISORS LP

1,837,261 sh

$53.1M

LMR Partners LLP

1,767,872 sh

$50.9M

Congress trades in SNN

STOCK Act disclosures, US House only, filed up to 45 days after the trade

Lisa McClain

Sold 2025-06-17 · disclosed 57 days later

$1,001 - $15,000

Lisa McClain

Bought 2025-06-09 · disclosed 65 days later

$1,001 - $15,000

All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings

Nobody has filed for crossing 5%. That is a fact, not missing data.

SNN planned insider sales (Form 144)

No planned-sale notices

No insider has filed to sell. Watch this after a run-up.

SNN mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).

AMG River Road Focused Absolute Value Fund

$1.7M position · as of 2026-07-31

3.8%

JOHCM International Opportunities Fund

$10.7M position · as of 2026-06-30

2.3%

Parvin Hedged Equity Solari World Fund

$282.1K position · as of 2026-05-31

2.1%

Brandes International ETF

$7.4M position · as of 2026-06-30

1.5%

Brandes International Equity Fund

$39.0M position · as of 2026-06-30

1.5%

AMG River Road Mid Cap Value Fund

$5.9M position · as of 2026-07-31

1.5%

SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio

Clinical pipeline

71 registered trials, 22 still running (ClinicalTrials.gov). A status change is dated here weeks before the press release.

Not applicable

22 active

What changed recently

Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 f

2026-10-28 · Completion moved 2026-09-30 → 2027-03-30

Not applicable

Knee Cartilage Repair Registry

2026-10-09 · Not Yet Recruiting → Recruiting

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

2026-09-29 · Completion moved 2026-08-15 → 2027-04-15

Not applicable

Matched by sponsor name. Trials run under a subsidiary's own name are not included.

Live price

Daily candles from TradingView, under their licence. No filings marked.

Show the live price chart

Why this name is on the desk

The complete filing record, in one place.

The record shows 171 funds added last quarter. Each figure is a federal filing, dated the day it went public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector by SEC SIC code

PEN BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX OM IRMD

SNN financials

Fundamentals

Annual figures from XBRL filings. Pick a past date to see them as known then.

	2025-12	2024-12	2023-12	2022-12
Gross profit	$4.2B	$4.0B	$3.8B	$3.7B
Net income	$625.0M	$412.0M	$263.0M	$223.0M

SEC XBRL, fiscal years, as known on 2026-10-28

SNN Stock Sonar score 2/7 axes

Find similar shapes Compare

Institutional and government

Inputs

Funds adding, latest quarter171 · 79 pct, sector of 191
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$1.9M · 92 pct, sector of 50

Risk and compliance

Inputs

Short interest, % of shares outstanding (no float on file)+0.5% · 82 pct, sector of 241
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)

5 not measured: Profitability, Financial health, Growth, Insider conviction, US patents

Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

SNN filings, in plain words

Have members of Congress traded SNN?

Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-06-17.

Read the full summary

Members of Congress have disclosed trades in SNN, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-06-17. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing

Insider buying Insider selling Congress stock trades Activist 13D stakes Form 144 planned sales CEO pay vs performance All companies